文献速递肿瘤 PET/CT

基线18F-FDG PET肿瘤参数与弥漫大B细胞淋巴瘤及霍奇金淋巴瘤循环DNA的相关性

Correlations between baseline 18F-FDG PET tumour parameters and circulating DNA in diffuse large B cell lymphoma and Hodgkin lymphoma.
PubMed 文献 · EJNMMI Res · 2020-10-07

结果显示描述肿瘤负荷、碎片化/巨块性和播散性的部分PET参数与血DNA参数显著相关,例如DLBCL中TMTS、medPCD和TumBB与ctDNA的相关系数分别为ρ=0.81、0.81和0.83(均p<0.001)。

要点

  • 基线PET参数可聚类为肿瘤负荷、碎片化/巨块性和播散性三类。
  • TMTS、medPCD和TumBB与DLBCL的ctDNA显著相关(ρ=0.81–0.83,p<0.001)。
  • 部分PET参数与循环DNA相关,有助于理解B细胞恶性肿瘤病理生理。

核心结论

  • 描述肿瘤负荷、碎片化/巨块性和播散性的部分PET参数与DLBCL和cHL患者的循环DNA参数显著相关。

主要发现

  • PET参数可观察到肿瘤负荷、碎片化/巨块性和播散性三个不同聚类。
  • DLBCL中总代谢肿瘤表面积(TMTS)与ctDNA相关(ρ=0.81,p<0.001)。
  • DLBCL中肿瘤周边至质心中位距离(medPCD)与ctDNA相关(ρ=0.81,p<0.001)。
  • DLBCL中包含肿瘤的包围盒体积(TumBB)与ctDNA相关(ρ=0.83,p<0.001)。

临床怎么用

  • 基线PET参数与循环DNA的相关性可用于理解B细胞恶性肿瘤的病理生理,但尚不能直接指导临床决策。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: 18F-FDG PET/CT is a standard for many B cell malignancies, while blood DNA measurements are emerging tools. Our objective was to evaluate the correlations between baseline PET parameters and circulating DNA in diffuse large B cell lymphoma (DLBCL) and classical Hodgkin lymphoma (cHL). METHODS: Twenty-seven DLBCL and forty-eight cHL were prospectively included. Twelve PET parameters were analysed. Spearman's correlations were used to compare PET parameters each other and to circulating cell-free DNA ([cfDNA]) and circulating tumour DNA ([ctDNA]). p values were controlled by Benjamini-Hochberg correction. RESULTS: Among the PET parameters, three different clusters for tumour burden, fragmentation/massiveness and dispersion parameters were observed. Some PET parameters were significantly correlated with blood DNA parameters, including the total metabolic tumour surface (TMTS) describing the tumour-host interface (e.g. ρ = 0.81 p < 0.001 for [ctDNA] of DLBLC), the tumour median distance between the periphery and the centroid (medPCD) describing the tumour's massiveness (e.g. ρ = 0.81 p < 0.001 for [ctDNA] of DLBLC) and the volume of the bounding box including tumours (TumBB) describing the disease's dispersion (e.g. ρ = 0.83 p < 0.001 for [ctDNA] of DLBLC). CONCLUSIONS: Some PET parameters describing tumour burden, fragmentation/massiveness and dispersion are significantly correlated with circulating DNA parameters of DLBCL and cHL patients. These results could help to understand the pathophysiology of B cell malignancies.

来源:EJNMMI Res,查看原文。版权归原作者所有。

引用

  1. Decazes P, Camus V, Bohers E, et al. Correlations between baseline 18F-FDG PET tumour parameters and circulating DNA in diffuse large B cell lymphoma and Hodgkin lymphoma. EJNMMI Res. 2020. PMID: 33029662. doi:10.1186/s13550-020-00717-y

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。